Rule 2.01.10(e)
Basis and Purpose:		Rule 2.01.10(e) is being amended to accommodate the implementation of the 
Electronic Prescription Drug Monitoring Program required by CRS 12-22-700.

Statement of Authority:	The Board is granted authority to promulgate rules pursuant to CRS sections 12-
22-108 and 110 and 24-4-103(2006)

2.01.10	Information to Appear on Each Order.  The following information must appear on 
each written or oral order except as provided for chart orders for hospitalized patients (hospital chart orders):

e.	In the case of a controlled substance order, the patient address, PATIENT BIRTHDATE, prescriber address, and prescriber’s DEA registration.

Rule 4.00.00
Basis and Purpose:		These rules are being amended to change how graduates of foreign pharmacy 
schools may be licensed as intern.
Statement of Authority:	The Board is granted authority to promulgate rules pursuant to CRS sections 12-
22-108 and 110 and 24-4-103(2006)

4.00.10  Interns		An intern must practice in conformity with the laws, rules, and regulations of the state in which 
he/she interns.

a.  The intern must obtain one thousand five hundred (1,500) hours of internship.

(1)  These hours may be obtained by participation in a rotation program conducted by an accredited school or college of pharmacy; and/or internship hours may be independently obtained by a licensed intern enrolled in, in good standing with, or having graduated from an approved school of pharmacy or holding a valid Foreign Pharmacy Graduate Equivalency Committee certificate.

(2)  Up to thirty (30) percent of the required hours may be obtained with a drug manufacturer under the supervision of such manufacturer or with a school or college of pharmacy in drug or drug related research activities as provided in CRS 12-22-111(1)(b)(i).

b.  An intern who fails to surrender his/her intern license upon the request of the Board, shall be deemed to be in violation of this regulation.  Although he/she may be granted the experience time submitted, administrative action may be instituted to suspend or revoke his/her license to practice as an intern, or to deny his/her license to practice as a pharmacist.

c.  A license to practice as an intern may be granted only to a person who has submitted satisfactory evidence that he/she has graduated from, is enrolled in, is in attendance at, or is in good standing with an accredited school or college of pharmacy, or has submitted to the Board a certificate issued by the Foreign Pharmacy Graduate Examination Commission.  If the applicant is a graduate of a foreign pharmacy school, the applicant must do the following:

	1.		Submit a Certificate from the Foreign Pharmacy Graduate Examination Committee (FPGEC); or

	2.		Submit documentation from FPGEC indicating that the applicant is not eligible for the FPGEC examination because his/her pharmacy degree is only equivalent to a Bachelor of Science degree.  Board staff may then refer the applicant to a different equivalency examination.  On the successful completion of this examination, an intern license may be issued

d.  A person on suspension from a school or college of pharmacy does not meet the definition of an intern and is not entitled to exercise the privileges of the intern license.

e.  A person who is in good standing with the school or college of pharmacy, but is not attending, may be licensed as an intern.

Rule 11.00.00
Basis and Purpose:		This rule is being amended to add schedule III, IV and V controlled substances to 
the rule.
Statement of Authority:	The Board is granted authority to promulgate rules pursuant to CRS sections 12-
22-108 and 110 and 24-4-103(2006)

11.04.10  A hard copy of every prescription order shall be readily retrievable and available for inspection for a period of two years from the date of any transaction relating to such prescription order unless the prescription drug outlet has received written Board approval to not retain the original prescription order for non-controlled drugs AND SCHEDULE III, IV, and V CONTROLLED SUBSTANCES.  Prescription orders will be deemed to be readily retrievable and available if they are filed according to the numerical sequence of the serial numbers assigned pursuant to 2.01.10.  In addition to being filed in numerical sequence, three different prescription files shall be maintained:  one file shall consist only of schedule II controlled substance prescription orders; the second file shall consist only of schedule III, IV and V controlled substance prescription orders; and the third file shall consist of all non-controlled substance prescription orders.  Filing of prescription orders in any manner other than by numerical sequence will result in such prescription orders being deemed not readily retrievable and available.

A hard copy of every chart order shall be readily retrievable and available for inspection for a period of two years from the date of any transaction relating to such order.  The LTCF chart orders will be deemed to be readily retrievable and available if they are filed according to the date of dispensing.  Chart orders for schedule III, IV, and V controlled substances shall be readily identifiable from non-controlled chart orders.  Schedule II orders shall be retained separately from all other orders.

If a prescription drug outlet utilizes both prescription orders and chart orders, assigning serial numbers to both with the same computer system, the orders must be filed sequentially by serial number.